lung neoplasms

ATS 2026: Addressing the Cough Assessment Gap in Respiratory Disease

ATS 2026 highlights the persistent gap in objective cough assessment in respiratory diseases, hindering precise diagnosis and treatment efficacy.

AI Integration Improves Lung Cancer MDT Workflow at ATS 2026

Integrating AI for lung cancer prediction into multidisciplinary team workflows demonstrates operational improvements and potential for enhanced patient stratification.

ATS 2026: Lung Cancer Management Advances in Targeted Therapy

ATS 2026 highlights evolving lung cancer management, focusing on precision medicine and novel targeted therapies for improved patient outcomes.

Does Vaping Cause Cancer? What the 2025–26 Evidence Shows

Three new papers assess carcinogenicity, toxicant exposure, and oral microbiota changes in vapers. The evidence is concerning but incomplete.